1. ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. (April 2016) Authors: Cuffe, Sinead; Azad, Abul Kalam; Qiu, Xiaoping; Qiu, Xin; Brhane, Yonathan; Kuang, Qin; Marsh, Sharon; Savas, Sevtap; Chen, Zhuo; Cheng, Dangxiao; Leighl, Natasha B.; Goss, Glenwood; Laurie, Scott A.; Seymour, Lesley; Bradbury, Penelope A.; Shepherd, Frances A.; Tsao, Ming Sound; Chen, Bingshu E.... Journal: Cancer epidemiology Issue: Volume 41(2016:Apr.) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute kidney Injury due to Alectinib, an Anaplastic Lymphoma Kinase inhibitor. Issue 1 (February 2021) Authors: Ng, Chin Lin; Abdalla, Alaeldin; Galambosi, Greta; Cuffe, Sinead; Doyle, Brendan; Griffin, Brenda; Sexton, Donal J Journal: Journal of onco-nephrology Issue: Volume 5:Issue 1(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial. (October 2022) Authors: Felip, Enriqueta; Smit, Egbert F.; Molina-Vila, Miguel A.; Dafni, Urania; Massuti, Bartomeu; Berghmans, Thierry; de Marinis, Filippo; Passiglia, Francesco; Dingemans, Anne-Marie C.; Cobo, Manuel; Viteri, Santiago; Britschgi, Christian; Cuffe, Sinead; Provencio, Mariano; Merkelbach-Bruse, Sabine; ... Journal: Lung cancer Issue: Volume 172(2022) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Altered expression of ACOX2 and other members of the peroxisome pathway in non-small cell lung cancer. (June 2021) Authors: Sui, Jane; Martin, Petra; Nicholson, Siobhan; Cuffe, Sinead; Finn, Stephen; Fitzmaurice, Gerard; Ryan, Ronan; Young, Vincent; Gray, Steven Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC. (1st August 2018) Authors: MacDonagh, Lauren; Gray, Steven G.; Breen, Eamon; Cuffe, Sinead; Finn, Stephen P.; O'Byrne, Kenneth J.; Barr, Martin P. Journal: Cancer letters Issue: Volume 428(2018) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cancer patients' acceptability of incorporating an epidemiology questionnaire within a clinical trial. (June 2015) Authors: Cuffe, Sinead; Hon, Henrique; Tobros, Kimberly; Espin-Garcia, Osvaldo; Brhane, Yonathan; Harland, Luke; Fadhel, Ehab; Eng, Lawson; LaDelfa, Anthony; Waldron, John; Siu, Lillian L; Chen, Bingshu E; Xu, Wei; Simmons, Christine; Kassam, Zahra; Montenegro, Alexander; Parulekar, Wendy R; Liu, Geoffrey Journal: Clinical trials Issue: Volume 12:Number 3(2015) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cancer survivors' experience of OptiMal, a 6-week, occupation-based, self-management intervention. (February 2019) Authors: Boland, Lauren; Bennett, Kathleen; Cuffe, Sinead; Gleeson, Noreen; Grant, Cliona; Kennedy, John; Connolly, Deirdre Journal: British journal of occupational therapy Issue: Volume 82:Number 2(2019) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Issue 5 (May 2017) Authors: Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massutí, Bartomeu; Palmero, Ramon; Aix, Santiago Ponce; Carcereny, Enric; Früh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios; Cuffe, Sinead; Bidoli, Paolo; Favaretto, ... Journal: Lancet Issue: Volume 5:Issue 5(2017) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%. Issue 21 (20th July 2021) Authors: Reck, Martin; Rodríguez-Abreu, Delvys; Robinson, Andrew G.; Hui, Rina; Csőszi, Tibor; Fülöp, Andrea; Gottfried, Maya; Peled, Nir; Tafreshi, Ali; Cuffe, Sinead; O'Brien, Mary; Rao, Suman; Hotta, Katsuyuki; Leal, Ticiana A.; Riess, Jonathan W.; Jensen, Erin; Zhao, Bin; Pietanza, M. Catherine; Brahm... Journal: Journal of clinical oncology Issue: Volume 39:Issue 21(2021) Page Start: 2339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. Issue 12 (December 2017) Authors: Brahmer, Julie R; Rodríguez-Abreu, Delvys; Robinson, Andrew G; Hui, Rina; Csőszi, Tibor; Fülöp, Andrea; Gottfried, Maya; Peled, Nir; Tafreshi, Ali; Cuffe, Sinead; O'Brien, Mary; Rao, Suman; Hotta, Katsuyuki; Zhang, Jin; Lubiniecki, Gregory M; Deitz, Anne C; Rangwala, Reshma; Reck, Martin Journal: Lancet oncology Issue: Volume 18:Issue 12(2017:Dec.) Page Start: 1600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗